Detalhe da pesquisa
1.
Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI.
Stroke
; 50(11): 3004-3012, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558144
2.
Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.
Haematologica
; 100(9): 1131-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113418
3.
Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations.
Bioorg Med Chem Lett
; 24(13): 2963-8, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24835983
4.
A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.
Bioorg Med Chem Lett
; 21(10): 2877-81, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21507636
5.
Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1.
J Cardiovasc Pharmacol Ther
; 19(2): 209-19, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24414167
6.
Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor.
Eur J Med Chem
; 65: 360-75, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23747805
7.
Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans.
J Am Coll Cardiol
; 61(7): 723-7, 2013 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23312702
8.
Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283.
J Med Chem
; 56(17): 7015-24, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23899349
9.
Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model.
J Cardiovasc Pharmacol Ther
; 17(2): 164-72, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697355
10.
Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model.
Thromb Res
; 130(4): 622-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909827
11.
Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y12 antagonist ticagrelor.
Thromb Haemost
; 106(6): 1179-88, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22071958
12.
Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Thromb Haemost
; 104(3): 609-17, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20694285
13.
Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques.
PLoS One
; 5(4): e10130, 2010 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20405028
14.
Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.
Cardiovasc Ther
; 27(4): 259-74, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604248
15.
Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.
Thromb Res
; 124(5): 565-71, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692114
16.
Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.
J Thromb Haemost
; 7(9): 1556-65, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19552634
17.
Reply: To PMID 23312702.
J Am Coll Cardiol
; 62(7): 647, 2013 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23747784
18.
Evaluation of platelet function, a method comparison.
Platelets
; 17(1): 49-55, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16308187
19.
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
Semin Thromb Hemost
; 31(2): 195-204, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15852223
20.
Dyspnoea and antiplatelet agents: revisited.
Int J Clin Pract
; 61(9): 1590; author reply 1591, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17686098